Singular Highlights Key G4X™ Launch Milestones and Showcases Groundbreaking 3D Spatial Multiomic Performance at AGBT
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 24 2025
0mins
Source: Newsfilter
G4X Spatial Sequencer Development: Singular Genomics announced key milestones for its G4X™ Spatial Sequencer at the AGBT conference, highlighting ongoing early access programs at major medical centers and plans for broader availability by June 2025.
Multiomic Performance and Innovations: The G4X platform demonstrated exceptional multiomic performance with high sensitivity and reproducibility in cancer research, showcasing advanced capabilities such as 3D reconstruction and direct sequencing of immune receptors in tissue samples.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
